Thus, patients with stage I, II, III, and IV stomach cancer have significantly higher overexpression of PYGB (p = 0.043), TNF (p = 0.02), HLA-A (0.05), and EFNB2 (0.001) genes, respectively (Fig. 2B). This evidence concerns the gene HLA-A and gastric cancer.